Dario Blood Glucose Monitoring System

System, Test, Blood Glucose, Over The Counter

LabStyle Innovations Ltd.

The following data is part of a premarket notification filed by Labstyle Innovations Ltd. with the FDA for Dario Blood Glucose Monitoring System.

Pre-market Notification Details

Device IDK150817
510k NumberK150817
Device Name:Dario Blood Glucose Monitoring System
ClassificationSystem, Test, Blood Glucose, Over The Counter
Applicant LabStyle Innovations Ltd. 3521 HATWYNN RD. Charlotte,  NC  28269
ContactTracey Wielinski
CorrespondentTracey Wielinski
LabStyle Innovations Ltd. 3521 HATWYNN RD. Charlotte,  NC  28269
Product CodeNBW  
Subsequent Product CodeCGA
Subsequent Product CodeJJX
CFR Regulation Number862.1345 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2015-03-27
Decision Date2015-12-21
Summary:summary

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
00850065006253 K150817 000
00850065006000 K150817 000
00850065006406 K150817 000
00850065006451 K150817 000
00850065006444 K150817 000
00850065006505 K150817 000
00850065006574 K150817 000
00850065006567 K150817 000
00850065006659 K150817 000
00850065006017 K150817 000
00850065006024 K150817 000
00850065006246 K150817 000
00850065006215 K150817 000
00850065006192 K150817 000
00850065006185 K150817 000
00850065006178 K150817 000
00850065006161 K150817 000
00850065006109 K150817 000
00850065006048 K150817 000
00850065006758 K150817 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.